Research suggests that certain weight loss drugs, including Ozempic, may have a relationship with cancer risk. Some studies indicate that these medications, known as GLP-1 drugs, could potentially lower the risk of breast cancer. However, the extent of this connection and whether the drugs can prevent cancer is still being explored and clarified.